Restoration of BRCA1 and BRCA2 mediates resistance to platinum chemotherapy in recurrent BRCA1 and BRCA2 mutated hereditary ovarian carcinomas [146]. The gene discussed is BRCA2; the disease is familial ovarian carcinoma.